OBJECTIVE: To describe features in patients admitted to the intensive care unit (ICU) for poor-grade aneurysmal subarachnoid hemorrhage (SAH) and to identify predictors of 12-month outcome. METHODS: We conducted a controlled observational study of 51 consecutive patients treated with endovascular coiling within 96 h of rupture for poor-grade aneurysmal SAH (20 men and 31 women, age 54 +/- 12 years). We recorded co-morbidities; initial severity; aneurysm location; occurrence of acute hydrocephalus, initial seizures, and/or neurogenic lung edema; troponin values, Fisher grade; computed tomography (CT) findings; treatment intensity; and occurrence of vasospasm. The brain injury marker S100B was assayed daily over the first 8 days. Glasgow Outcome Scores (GOS) were recorded at ICU discharge, at 6 and 12 months. The main outcome criterion was the 1-year GOS score, which we used to classify patients as having a poor outcome (GOS 1-3) or a good outcome (GOS 4-5). RESULTS: Overall, clinical status after 1 year was very good (GOS 5) in 41% of patients and good (GOS 4) in 16%. Neither baseline characteristics nor interventions differed significantly between patients with good outcome (GOS 4-5) and those with poor outcome (GOS 1-3). Persistent intracranial pressure elevation and higher mean 8-day S100B value significantly and independently predicted the 1-year GOS outcome (P = 0.008 and P = 0.001, respectively). CONCLUSIONS: Patients in poor clinical condition after SAH have more than a 50:50 chance of a favorable outcome after 1 year. High mean 8-day S100B value and persistent intracranial hypertension predict a poor outcome (GOS 1-3) after 1 year.
OBJECTIVE: To describe features in patients admitted to the intensive care unit (ICU) for poor-grade aneurysmal subarachnoid hemorrhage (SAH) and to identify predictors of 12-month outcome. METHODS: We conducted a controlled observational study of 51 consecutive patients treated with endovascular coiling within 96 h of rupture for poor-grade aneurysmal SAH (20 men and 31 women, age 54 +/- 12 years). We recorded co-morbidities; initial severity; aneurysm location; occurrence of acute hydrocephalus, initial seizures, and/or neurogenic lung edema; troponin values, Fisher grade; computed tomography (CT) findings; treatment intensity; and occurrence of vasospasm. The brain injury marker S100B was assayed daily over the first 8 days. Glasgow Outcome Scores (GOS) were recorded at ICU discharge, at 6 and 12 months. The main outcome criterion was the 1-year GOS score, which we used to classify patients as having a poor outcome (GOS 1-3) or a good outcome (GOS 4-5). RESULTS: Overall, clinical status after 1 year was very good (GOS 5) in 41% of patients and good (GOS 4) in 16%. Neither baseline characteristics nor interventions differed significantly between patients with good outcome (GOS 4-5) and those with poor outcome (GOS 1-3). Persistent intracranial pressure elevation and higher mean 8-day S100B value significantly and independently predicted the 1-year GOS outcome (P = 0.008 and P = 0.001, respectively). CONCLUSIONS:Patients in poor clinical condition after SAH have more than a 50:50 chance of a favorable outcome after 1 year. High mean 8-day S100B value and persistent intracranial hypertension predict a poor outcome (GOS 1-3) after 1 year.
Authors: J Sen; A Belli; A Petzold; S Russo; G Keir; E J Thompson; M Smith; N Kitchen Journal: Acta Neurochir (Wien) Date: 2005-04-25 Impact factor: 2.216
Authors: William J Mack; Ryan G King; Andrew F Ducruet; Kurt Kreiter; J Mocco; Ahmed Maghoub; Stephan Mayer; E Sander Connolly Journal: Neurosurg Focus Date: 2003-04-15 Impact factor: 4.047
Authors: M Johansson; O Norbäck; G Gál; K G Cesarini; M Tovi; S Solander; C F Contant; E Ronne-Engström; P Enblad Journal: Neuroradiology Date: 2004-04-17 Impact factor: 2.804
Authors: Christopher J Taylor; Fergus Robertson; David Brealey; Frankie O'shea; Tina Stephen; Stefan Brew; Joan P Grieve; Martin Smith; Ian Appleby Journal: Neurocrit Care Date: 2011-06 Impact factor: 3.210
Authors: Kentaro Murakami; Masayo Koide; Travis M Dumont; Sheila R Russell; Bruce I Tranmer; George C Wellman Journal: Transl Stroke Res Date: 2011-03-01 Impact factor: 6.829
Authors: D Mitra; B Gregson; V Jayakrishnan; A Gholkar; A Vincent; P White; P Mitchell Journal: AJNR Am J Neuroradiol Date: 2014-07-24 Impact factor: 3.825